Literature DB >> 6274390

Spin-label detection of hemoglobin-membrane interaction at physiological pH.

L W Fung.   

Abstract

The interaction between hemoglobin and the cytoplasmic surface of human erythrocyte membranes at physiological pH was studied by monitoring the electron paramagnetic resonance (EPR) signal of spin-labeled membrane ghosts in hemoglobin solutions of various concentrations. The EPR spectra indicate the existence of a significant hemoglobin-membrane interaction which exhibits a substantial hemoglobin concentration dependence over the concentration range 0-12 mg/mL. An equilibrium binding model yields a hemoglobin-membrane dissociation constant, Kd, on the order of 10(-4) M, at and above physiological pH; the interaction is classified as very low-affinity binding. The interaction increases significantly when the pH is decreased. Half-saturation of the binding sites occurs at a ratio of about 10(8) hemoglobins per cell.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6274390     DOI: 10.1021/bi00528a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Erythrocyte spectrin maintains its segmental motions on oxidation: a spin-label EPR study.

Authors:  L W Fung; B O Kalaw; R M Hatfield; M N Dias
Journal:  Biophys J       Date:  1996-02       Impact factor: 4.033

Review 2.  Interaction of hemoglobin with band 3: a review.

Authors:  R K Kaul; H Köhler
Journal:  Klin Wochenschr       Date:  1983-09-01

3.  Temperature dependence of spin-label intensity in solutions and its implication in spin-labeled erythrocyte membrane studies.

Authors:  L W Fung; M E Johnson
Journal:  Biophys J       Date:  1983-08       Impact factor: 4.033

4.  Binding of hemoglobin to red cell membranes with eosin-5-maleimide-labeled band 3: analysis of centrifugation and fluorescence data.

Authors:  Afolorunso Andrew Demehin; Omoefe O Abugo; Rajadas Jayakumar; Joseph R Lakowicz; Joseph M Rifkind
Journal:  Biochemistry       Date:  2002-07-09       Impact factor: 3.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.